MedPath

The Effect of Interscalene Block on Intracranial Pressure

Not Applicable
Conditions
Brachial Plexus Block
Intracranial Pressure Increase
Interventions
Procedure: Interscalene brachial plexus block
Registration Number
NCT05434975
Lead Sponsor
Cumhuriyet University
Brief Summary

The study aims to show the effects of interscalene brachial plexus (ISBP) block on intracranial pressure by measuring optic nerve sheath diameter (ONSD) and internal vein collapsibility index (IJV-CI).

Detailed Description

40 is the targeted number of patients who are going to have humerus fracture or opened rotator-cuff surgery. Single shot-ISBP block with 25 ml local anesthetic will be performed as anesthetic approach for surgery to all participants. Intraoperative ONSD and IJV-CI measurements will be performed before the ISBP block, 20 minutes and 60 minutes after the block. Hypothesis; external drug-volume effect on internal jugular vein causes decreasing maximum diameter of internal jugular vein (Dmax), venous return from cranium to heart decreases, intracranial pressure can increase.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients who had elective humeral fracture and open rotator-cuff surgery,
  • Patients aged 18-85 years,
  • Patients have ASA I-II anesthesia risk according to the American Society of Anesthesiologists (ASA) risk classification,
  • Patients that gave consent for participation in the study will be included.
Exclusion Criteria
  • Patients who do not give consent to the study,
  • Patients with infection and open wounds in the area of skin puncture and eyelids,
  • Patients have any history of intracranial pathology,
  • Patients have nerve blockade contraindications such as coagulation disorder and antithrombotic-anticoagulant use,
  • Patients have a history of allergy to one of the study drugs,
  • Patients have a body mass index over 35 kg/m2,
  • Patients with contralateral pneumothorax,
  • Patients with severe respiratory distress,
  • Patients with uncontrolled hypertension,
  • Patients with acute or chronic eye disease,
  • Patients with previous eye surgery,
  • Patients using a beta-blocker known to increase intraocular pressure,
  • Patients using calcium channel blockers, statins and nitrates,
  • Patients in need of intraoperative sedation,
  • Patients who develope any complications (hoarseness, horner's syndrome, respiratory distress, local anesthetic toxicity) due to ISBP block will be excluded from the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
BlockedInterscalene brachial plexus blockAll participants will have single-shot interscalene brachial plexus block with same technique. There is no comparing.
Primary Outcome Measures
NameTimeMethod
Optic nerve sheath diameter changeOptic nerve sheath diameter will be measured before the block (basal) and it will be measured at 20th and 60th minutes after the block. The change between the measurements of basal and 60th minute and change between basal and 20th minute will be assessed

Optic nerve sheath diameter will be measured as a unit of millimeter.

Maximum diameter of internal jugular vein (Dmax) changeDmax will be measured before the block (basal) and it will be measured at 20th and 60th minutes after the block. The change between the measurements of basal and 60th minute, and change between basal and 20th minute will be assessed

Dmax will be measured as a unit of millimeter

Minimum diameter of internal jugular vein (Dmin) changeDmin will be measured before the block (basal) and it will be measured at 20th and 60th minutes after the block. The change between the measurements of basal and 60th minute, and change between basal and 20th minute will be assessed

Dmin will be measured as a unit of millimeter

Internal jugular vein collapsibility index (IJV-CI) changeIJV-CI will be measured before the block (basal) and it will be measured at 20th and 60th minutes after the block. The change between the measurements of basal and 60th minute, and change between basal and 20th minute will be assessed

IJV-CI will be measured as a unit of %.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sivas Cumhuriyet University

🇹🇷

Sivas, Turkey

© Copyright 2025. All Rights Reserved by MedPath